Clinical Trial Update: Heparin Antibodies in Intensive Care Unit Patients (HAICU)

View source ↗

Summary

The HAICU trial update indicates that the study evaluating heparin antibodies in ICU patients with heparin-induced thrombocytopenia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heparin-induced Thrombocytopenia

Snippet

Sponsor: The University of Texas Health Science Center, Houston | Conditions: Heparin-Induced Thrombocytopenia | Status: COMPLETED